|
|
| Maladies Respiratoires > Etude de marché sectorielle |
| US State Market Index: Drugs acting on the respiratory system |
|
|
|
|
€ 475,00 |
Editeur
: |
BizMiner |
Langue
: |
Anglais |
Date de publication : |
Juillet 2006 |
Taille du document : |
12 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
|
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
Partneringreview 2006 Vol 2 Ch 7: Respiratory (PR06V2C07)
112 pages | Février 2006 |
Partneringreview 2006 – Therapy area Respiratory provides an in depth view into the respiratory disease focused deals and alliances announced in 2005, in a clear and accessible format.
The report |
795,00 €
|
| |
| |
Commercial Insight: Asthma and COPD - Get SMART
136 pages | Novembre 2005 |
IntroductionThere is a positive outlook for the respiratory market over the next five years, which will experience a sustained period of growth driven by the expansion of sales in existing classes, th |
12 920,00 €
|
| |
| |
Travel and Tourism - Poland
34 pages | Août 2006 |
About this reportSince its break with communism in 1989 and its first democratic election Poland has become an increasingly popular destination choice for foreign tourists.
This diverse country boa |
445,00 €
|
| |
| |
Inhalable Drug Delivery: Industry Holds its Breath in Anticipation of Systemic Success
124 pages | Décembre 2005 |
IntroductionCurrently driven by the needs of the expanding respiratory market, the inhalable drug delivery sector has also been invigorated by the promise of growth through the systemic delivery of dr |
6 460,00 €
|
| |
| |
New Drugs in Development for Acute Respiratory Distress Syndrome
1 pages | Janvier 2006 |
This Database Table is a one-page table of hard-to-find numerical information.
The Database Table is derived from a proprietary source and is meant to simply provide a high-level overview of specif |
80,00 €
|
| |
| |
US Cough Syrup 2004
12 pages | Juillet 2004 |
Snapdata's US Cough Syrup 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US cough syrup market, and covers |
240,00 €
|
| |
| |
OTC Cough and Cold Remedies in Germany
10 pages | Juin 2005 |
Euromonitor International’s ‘OTC Cough and Cold Remedies in Germany' Major Market Profile report offers an introduction to the market.
It is c.
10 pages long and provides a top line overview of |
198,00 €
|
| |
| |
New Drugs in Development for Asthma
1 pages | Janvier 2006 |
This Database Table is a one-page table of hard-to-find numerical information.
The Database Table is derived from a proprietary source and is meant to simply provide a high-level overview of specif |
80,00 €
|
| |
| |
Pipeline Insight Asthma/COPD/Allergic Rhinitis - As Patents Expire, Novel Combinations Inspire
124 pages | Avril 2005 |
IntroductionThe asthma, COPD and allergic rhinitis global market was $25.5 billion in 2004, with five brands selling over $1.0 billion.
While a number of moderately successful launches are expected |
9 120,00 €
|
| |
| |
Respiratory Handbook 2005-15: Novartis Moving Into the Major League
51 pages | Juin 2005 |
IntroductionThe respiratory market has experienced below average growth in the last five years (CAGR, 10%) reaching $25.5bn in 2004 in the seven major pharmaceutical markets.
Future growth will be |
3 040,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
| US State Market Index: Drugs acting on the respiratory system |
|
|
The metrics in this report cover three year trends in Drugs acting on the respiratory system [Manufacturing sector], broken out on a state-by-state basis. Analysis is based on data applied from 29 industry firms. Industry market vitality measures for each state are benchmarked against US averages for the industry, creating easy comparison of state-by-state performance. Industry sales are detailed for both company-wide headquarters data and locally generated sales levels. The report also compares proprietary measures in each state and the US, including failure rates, entrepreneurial activity and new branch development rates in the industry.
|
|
State Market Index Contents
P1-3 Introduction and context for the measures
P4:Industry population and segmentation
P5:Establishment,company and branch failure rates
P6:Total industry sales volume (reported and locally generated)
P7:Average annual reported sales
P8:Average annual generated sales
P9:Startup activity, new branch development,employment concentration
P10:Overall Index
P11:About the data
|
|
|
PPLSEN
|
|
|
|
|
